Circulating tumor (ct)-DNA alterations in patients with testicular germ cell tumors.

Authors

null

Archana Agarwal

Dana Farber Cancer Institute at St. Elizabeth's Medical Center, Brighton, MA

Archana Agarwal , Amin Nassar , Rebecca Nagy , Catherine Curran , Sarah Abou Alaiwi , Richard B. Lanman , AmirAli Talasaz , Christopher Sweeney , Guru Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 415)

Abstract #

415

Poster Bd #

E14

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors.

Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors.

First Author: Sean Q. Kern

Poster

2022 ASCO Genitourinary Cancers Symposium

Molecular analysis of primary testicular germ cell tumor and matched metastatic teratomas.

Molecular analysis of primary testicular germ cell tumor and matched metastatic teratomas.

First Author: Anna Savelyeva

Poster

2021 Genitourinary Cancers Symposium

Comprehensive genomic profiling (CGP) in patients with relapsed/refractory germ cell tumors (GCT).

Comprehensive genomic profiling (CGP) in patients with relapsed/refractory germ cell tumors (GCT).

First Author: Reem Akel

Poster

2016 Genitourinary Cancers Symposium

Actionable targets in patients with cisplatin-resistant advanced germ cell tumors.

Actionable targets in patients with cisplatin-resistant advanced germ cell tumors.

First Author: Aditya Bagrodia